The molecular and clinical implications of CECR2 in cancer remain largely unknown, although a very recent report revealed that CECR2 is a driver for breast cancer metastasis by promoting NF-kB signaling and macrophage-mediated immune suppression [184]. The gene discussed is CECR2; the disease is breast carcinoma.